1974
DOI: 10.2165/00003495-197407010-00007
|View full text |Cite
|
Sign up to set email alerts
|

??-Adrenergic Receptor Blocking Drugs in Hypertrophic Cardiomyopathy, Autonomically Mediated Cardiovascular Functional Disorders and Fallot??s Tetralogy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
1
0

Year Published

1976
1976
2009
2009

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 35 publications
2
1
0
Order By: Relevance
“…In agreement with previous experience with beta-blocking treatment of such a syndrome [13][14][15][16][17][18][19][20][21][22][23][24][25], bisoprolol showed a better effect with respect to diazepam in reducing somatic aspects, particularly the cardiovascular symptoms, such as tachycardia, palpitations, and atypical chest pain. Bisoprolol also demonstrated the ability to improve the psychic profile of anxiety, confirming the possibility that the control of autonomically mediated symptoms may favorably affect the mental state, as previously suggested by some authors [21,22].…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…In agreement with previous experience with beta-blocking treatment of such a syndrome [13][14][15][16][17][18][19][20][21][22][23][24][25], bisoprolol showed a better effect with respect to diazepam in reducing somatic aspects, particularly the cardiovascular symptoms, such as tachycardia, palpitations, and atypical chest pain. Bisoprolol also demonstrated the ability to improve the psychic profile of anxiety, confirming the possibility that the control of autonomically mediated symptoms may favorably affect the mental state, as previously suggested by some authors [21,22].…”
Section: Discussionsupporting
confidence: 90%
“…In conclusion, bisoprolol was as effective as diazepam in the treatment of cardiac neurosis, but with a more pronounced effect on somatic symptoms related to the beta-adrenergic-mediated hyperdynamic state, which confirms previous observations with other beta blockers, both betal-selective and nonselective [13][14][15][16][17][18][19][20][21][22][23][24][25][28][29][30]. As a result of several reports in the literature, the presence of betal-selectivity, ISA, and lipophilicity do not appear to substantially affect the neuropsychiatric use of beta blockers [18,[28][29][30]41,42].…”
Section: Hamilton Rating Scalessupporting
confidence: 87%
See 1 more Smart Citation